Warner Biddle
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Warner Biddle currently works at Kyverna Therapeutics, Inc., as Chief Executive Officer & Director from 2024.
Mr. Biddle also formerly worked at Genentech, Inc., as Vice President-Sales & Marketing and Kite Pharma, Inc., as Senior Vice President & Global Head-Commercial.
Mr. Biddle received his undergraduate degree from the University of Saskatchewan.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Directeur Général | 16/09/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Sales & Marketing | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of Saskatchewan
University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national